NCT04723095View on ClinicalTrials.gov

Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix

RecruitingOBSERVATIONAL
Enrollment

750

Participants

Timeline

Start Date

May 16, 2013

Primary Completion Date

January 1, 2044

Study Completion Date

January 1, 2044

Conditions
Cervical Large Cell Neuroendocrine CarcinomaCervical Neuroendocrine CarcinomaCervical Small Cell CarcinomaCervical Undifferentiated CarcinomaStage I Cervical Cancer AJCC v8Stage IA Cervical Cancer AJCC v8Stage IA1 Cervical Cancer AJCC v8Stage IA2 Cervical Cancer AJCC v8Stage IB Cervical Cancer AJCC v8Stage IB1 Cervical Cancer AJCC v8Stage IB2 Cervical Cancer AJCC v8Stage II Cervical Cancer AJCC v8Stage IIA Cervical Cancer AJCC v8Stage IIA1 Cervical Cancer AJCC v8Stage IIA2 Cervical Cancer AJCC v8Stage IIB Cervical Cancer AJCC v8Stage III Cervical Cancer AJCC v8Stage IIIA Cervical Cancer AJCC v8Stage IIIB Cervical Cancer AJCC v8Stage IV Cervical Cancer AJCC v8Stage IVA Cervical Cancer AJCC v8Stage IVB Cervical Cancer AJCC v8
Interventions
OTHER

Follow-Up

Receive follow up

OTHER

Medical Chart Review

Review of medical records

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER